BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12200358)

  • 1. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.
    Sierra J; Pérez WS; Rozman C; Carreras E; Klein JP; Rizzo JD; Davies SM; Lazarus HM; Bredeson CN; Marks DI; Canals C; Boogaerts MA; Goldman J; Champlin RE; Keating A; Weisdorf DJ; de Witte TM; Horowitz MM
    Blood; 2002 Sep; 100(6):1997-2004. PubMed ID: 12200358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes.
    Guardiola P; Runde V; Bacigalupo A; Ruutu T; Locatelli F; Boogaerts MA; Pagliuca A; Cornelissen JJ; Schouten HC; Carreras E; Finke J; van Biezen A; Brand R; Niederwieser D; Gluckman E; de Witte TM;
    Blood; 2002 Jun; 99(12):4370-8. PubMed ID: 12036864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
    Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
    Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.
    Castro-Malaspina H; Jabubowski AA; Papadopoulos EB; Boulad F; Young JW; Kernan NA; Perales MA; Small TN; Hsu K; Chiu M; Heller G; Collins NH; Jhanwar SC; van den Brink M; Nimer SD; O'Reilly RJ
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):458-68. PubMed ID: 18342789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience.
    Parikh SH; Mendizabal A; Martin PL; Prasad VK; Szabolcs P; Driscoll TA; Kurtzberg J
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):948-55. PubMed ID: 19589484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
    Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
    N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
    Deeg HJ; Shulman HM; Anderson JE; Bryant EM; Gooley TA; Slattery JT; Anasetti C; Fefer A; Storb R; Appelbaum FR
    Blood; 2000 Feb; 95(4):1188-94. PubMed ID: 10666189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
    Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
    Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.
    Shaw PJ; Kan F; Woo Ahn K; Spellman SR; Aljurf M; Ayas M; Burke M; Cairo MS; Chen AR; Davies SM; Frangoul H; Gajewski J; Gale RP; Godder K; Hale GA; Heemskerk MB; Horan J; Kamani N; Kasow KA; Chan KW; Lee SJ; Leung WH; Lewis VA; Miklos D; Oudshoorn M; Petersdorf EW; Ringdén O; Sanders J; Schultz KR; Seber A; Setterholm M; Wall DA; Yu L; Pulsipher MA
    Blood; 2010 Nov; 116(19):4007-15. PubMed ID: 20671124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome].
    Zhao T; Huang X; Liu D; Wang J; Zhang X; Wang Y; Han W; Chen H; Chen Y; Wang F; Liu K; Xu L
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):89-93. PubMed ID: 24767157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.
    Couban S; Simpson DR; Barnett MJ; Bredeson C; Hubesch L; Howson-Jan K; Shore TB; Walker IR; Browett P; Messner HA; Panzarella T; Lipton JH;
    Blood; 2002 Sep; 100(5):1525-31. PubMed ID: 12176866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of partially mismatched related donors extends access to allogeneic marrow transplant.
    Henslee-Downey PJ; Abhyankar SH; Parrish RS; Pati AR; Godder KT; Neglia WJ; Goon-Johnson KS; Geier SS; Lee CG; Gee AP
    Blood; 1997 May; 89(10):3864-72. PubMed ID: 9160695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents.
    Watanabe T; Takaue Y; Kawano Y; Koike K; Kikuta A; Imaizumi M; Watanabe A; Eguchi H; Ohta S; Horikoshi Y; Iwai A; Makimoto A; Kuroda Y;
    Biol Blood Marrow Transplant; 2002; 8(1):26-31. PubMed ID: 11846353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
    van Rood JJ; Loberiza FR; Zhang MJ; Oudshoorn M; Claas F; Cairo MS; Champlin RE; Gale RP; Ringdén O; Hows JM; Horowitz MH
    Blood; 2002 Mar; 99(5):1572-7. PubMed ID: 11861270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.
    Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA
    Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.